JPMorgan Chase & Co’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-17
| Closed | – | – | 6272 |
|
|
2022
Q3 | $0 | Hold |
17
| – | – | ﹤0.01% | 6071 |
|
|
2022
Q2 | $0 | Sell |
17
-2,000
| -99% | – | ﹤0.01% | 6155 |
|
|
2022
Q1 | $3K | Buy |
2,017
+2,000
| +11,765% | +$2.98K | ﹤0.01% | 5575 |
|
|
2021
Q4 | $0 | Hold |
17
| – | – | ﹤0.01% | 6099 |
|
|
2021
Q3 | $0 | Sell |
17
-76,589
| -100% | – | ﹤0.01% | 5901 |
|
|
2021
Q2 | $285K | Buy |
76,606
+5,732
| +8% | +$21.3K | ﹤0.01% | 4312 |
|
|
2021
Q1 | $245K | Buy |
70,874
+29,868
| +73% | +$103K | ﹤0.01% | 4378 |
|
|
2020
Q4 | $138K | Buy |
41,006
+35,284
| +617% | +$119K | ﹤0.01% | 4238 |
|
|
2020
Q3 | $20K | Buy |
5,722
+673
| +13% | +$2.35K | ﹤0.01% | 4489 |
|
|
2020
Q2 | $23K | Buy |
5,049
+648
| +15% | +$2.95K | ﹤0.01% | 4393 |
|
|
2020
Q1 | $15K | Sell |
4,401
-1,604
| -27% | -$5.47K | ﹤0.01% | 4408 |
|
|
2019
Q4 | $36K | Buy |
6,005
+1,507
| +34% | +$9.03K | ﹤0.01% | 4328 |
|
|
2019
Q3 | $19K | Buy |
4,498
+729
| +19% | +$3.08K | ﹤0.01% | 4493 |
|
|
2019
Q2 | $48K | Buy |
+3,769
| New | +$48K | ﹤0.01% | 4269 |
|